Bendamustine

Results: 29



#Item
11BBD Poster ASH 2. Dec 2011_EV

BBD Poster ASH 2. Dec 2011_EV

Add to Reading List

Source URL: myeloma.org

Language: English - Date: 2012-04-18 11:56:14
12JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area  Product Name

JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON SELECTED PHARMACEUTICALS IN LATE STAGE U.S. AND E.U. DEVELOPMENT OR REGISTRATION as of[removed]Therapeutic Area Product Name

Add to Reading List

Source URL: files.shareholder.com

Language: English
13National Cancer Drugs Fund List

National Cancer Drugs Fund List

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2015-01-12 11:24:30
14HIGHLIGHTS OF PRESCRIBING INFORMATION	 These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA® (bendamustine hydrochloride

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TREANDA safely and effectively. See full prescribing information for TREANDA. TREANDA® (bendamustine hydrochloride

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-09-17 10:57:15
15Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance and Dru

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology Pediatric Postmarketing Pharmacovigilance and Dru

Add to Reading List

Source URL: www.fda.gov

Language: English
16Bendamustine hydrochloride 22-249S012  Clinpharm PREA

Bendamustine hydrochloride 22-249S012 Clinpharm PREA

Add to Reading List

Source URL: www.fda.gov

Language: English
17A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista

A Canadian Perspective on the Treatment of Unfit Patients with Chronic Lymphocytic Leukemia David MacDonald, MD, FRCP(C);* Silvy Lachance, MD, FRCP(C), CSPQ;† Loree Larratt, MD, FRCP(C)‡ *Dr. David MacDonald, Assista

Add to Reading List

Source URL: www.newevidence.com

Language: English - Date: 2013-05-06 11:02:45
18National Cancer Drugs Fund List Ver2.1 Ver2.1  National CDF List

National Cancer Drugs Fund List Ver2.1 Ver2.1 National CDF List

Add to Reading List

Source URL: www.england.nhs.uk

Language: English - Date: 2014-10-30 05:44:04
19Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials  Pediatric Advisory Committee Meeting, September 23, 2014

Treanda (bendamustine hydrochloride) Full Safety and Drug Utilization Review Provided in Background Materials Pediatric Advisory Committee Meeting, September 23, 2014

Add to Reading List

Source URL: www.fda.gov

Language: English
2022249 Bendamustine Amendment 2

22249 Bendamustine Amendment 2

Add to Reading List

Source URL: www.fda.gov

Language: English